Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mark

Showing results (491-500 of 535) with videos related to

Pageof 54
Sort By:
Bone Marrow Transplantation|June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myelomaAlexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
British Journal of Haematology|February 8, 2021
Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trialVania Hungria, Meral Beksac, Katja C Weisel, et al.
American Journal of Hematology|February 12, 2019
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myelomaPeter A Forsberg, Adriana C Rossi, Angelique Boyer, et al.
JCI Insight|May 6, 2020
Tubular β-catenin and FoxO3 interactions protect in chronic kidney diseaseStellor Nlandu-Khodo, Yosuke Osaki, Lauren Scarfe, et al.
ESMO Open|April 15, 2022
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 studyM Mark, S Rusakiewicz, M Früh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2020
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)Y Metaxas, M Früh, E I Eboulet, et al.
Cancer Research|July 11, 2018
SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut EpitheliumAnsu O Perekatt, Pooja P Shah, Shannon Cheung, et al.
Nature Communications|November 23, 2018
Hedgehog stimulates hair follicle neogenesis by creating inductive dermis during murine skin wound healingChae Ho Lim, Qi Sun, Karan Ratti, et al.
Cancer Letters|September 20, 2021
Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancerKeita Hanada, Kenji Kawada, Gen Nishikawa, et al.
Trends in Cancer|March 13, 2025
Leveraging space innovations for cancer breakthroughs on EarthHossein Akbarialiabad, Parnian Jamshidi, Zahra Aminzade, et al.
Pageof 54

Showing results (491-500 of 535) with videos related to

Sort By:
Pageof 54
Bone Marrow Transplantation|June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myelomaAlexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
British Journal of Haematology|February 8, 2021
Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trialVania Hungria, Meral Beksac, Katja C Weisel, et al.
American Journal of Hematology|February 12, 2019
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myelomaPeter A Forsberg, Adriana C Rossi, Angelique Boyer, et al.
JCI Insight|May 6, 2020
Tubular β-catenin and FoxO3 interactions protect in chronic kidney diseaseStellor Nlandu-Khodo, Yosuke Osaki, Lauren Scarfe, et al.
ESMO Open|April 15, 2022
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 studyM Mark, S Rusakiewicz, M Früh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2020
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)Y Metaxas, M Früh, E I Eboulet, et al.
Cancer Research|July 11, 2018
SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut EpitheliumAnsu O Perekatt, Pooja P Shah, Shannon Cheung, et al.
Nature Communications|November 23, 2018
Hedgehog stimulates hair follicle neogenesis by creating inductive dermis during murine skin wound healingChae Ho Lim, Qi Sun, Karan Ratti, et al.
Cancer Letters|September 20, 2021
Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancerKeita Hanada, Kenji Kawada, Gen Nishikawa, et al.
Trends in Cancer|March 13, 2025
Leveraging space innovations for cancer breakthroughs on EarthHossein Akbarialiabad, Parnian Jamshidi, Zahra Aminzade, et al.
Pageof 54